CASI Pharmaceuticals, Inc.
CASIF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.09M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.09 Million |
|---|---|
| Enterprise Value | $39.83 Million |
| Earnings per Share | $-2.59 |
| Beta | 1.34 |
| Outstanding Shares | 20,555,901 |
Return
| Return on Equity | 75.45% |
|---|---|
| Return on Assets | -208.70% |
| Return on Invested Capital | 87.72% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | 0.17 |
| Price to Sales | - |
| Price to Book Ratio | -0.03 |
| Enterprise Value to Revenue | 1.98 |
| Enterprise Value to EBIT | -1 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.02 |
| Debt to Equity | -0.7 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 2, 2026
EPS Estimate
$-0.35
Consensus analyst estimateRevenue Estimate
$4.91 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-0.35
Consensus analyst estimateRevenue Estimate
$4.84 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About CASI Pharmaceuticals Inc
214 employees
CEO: Wei-Wu He
CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on...